David Von Schack

David Von Schack

Pfizer Inc. - New York / United States
Medical and Health Sciences / Neuroscience
AD Scientific Index ID: 4394143
-
person_outline David Von Schack's MOST POPULAR ARTICLES
1-) Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivoM Yadav, C Louvet, D Davini, JM Gardner, M Martinez-Llordella, ...Journal of Experimental Medicine 209 (10), 1713-1722, 20127392012
2-) Complete ablation of the neurotrophin receptor p75NTR causes defects both in the nervous and the vascular systemD von Schack, E Casademunt, R Schweigreiter, M Meyer, M Bibel, ...Nature neuroscience 4 (10), 977-978, 20013072001
3-) Divergent phenotypes of human regulatory T cells expressing the receptors TIGIT and CD226CA Fuhrman, WI Yeh, HR Seay, P Saikumar Lakshmi, G Chopra, L Zhang, ...The Journal of Immunology 195 (1), 145-155, 20152502015
4-) Evaluation of two main RNA-seq approaches for gene quantification in clinical RNA sequencing: polyA+ selection versus rRNA depletionS Zhao, Y Zhang, R Gamini, B Zhang, D Von SchackScientific reports 8 (1), 4781, 20182492018
5-) Dynamic changes in the microRNA expression profile reveal multiple regulatory mechanisms in the spinal nerve ligation model of neuropathic painD von Schack, MJ Agostino, BS Murray, Y Li, PS Reddy, J Chen, SE Choe, ...PloS one 6 (3), e17670, 20111662011